CJC-1295 No DAC / Modified GRF (1-29)

CJC-1295 No DAC is a synthetic research peptide related to GHRH (Growth Hormone-Releasing Hormone). In the research-peptide market, the term “CJC-1295 No DAC” is commonly used to refer to Modified GRF (1-29), a short-acting GHRH analog.

Unlike CJC-1295 with DAC, this version does not incorporate a Drug Affinity Complex (DAC) modification and therefore lacks the albumin-binding design responsible for the prolonged pharmacokinetic profile of the DAC-containing form. This makes it relevant to research involving shorter-duration and pulsatile GHRH/GH signaling.

In endocrine research, CJC-1295 No DAC is investigated in connection with GHRH receptor activation, pituitary GH release, pulsatile growth hormone signaling, the GH/IGF-1 axis, and associated endocrine and metabolic regulatory mechanisms.

It can also serve as an experimental tool for comparing short-acting GHRH analogs with DAC-containing long-acting analogs in terms of receptor signaling, duration of activity, and endocrine responses.

CJC-1295 No DAC / Modified GRF (1-29) remains a research compound and should not be represented as having established muscle-building, fat-loss, anti-aging, or performance-enhancing effects in humans.

La livraison est facturée selon le nombre d'articles de la commande, aux mêmes tarifs pour toutes les destinations, et le montant exact s'affiche au moment du paiement, avant de payer. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.